Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Conference News SCCT 2025

Leaders in Cardiac CT Look Back on 20 Years of Growth Despite Challenges

Yael L. Maxwell

July 25, 2025

News Conference News ESC 2024

OCCUPI: OCT Guidance Improves Outcomes in Complex PCI

Shelley Wood

September 03, 2024

News Conference News SCCT 2023

Do Guidelines Make a Difference? SCCT Session Probes Impact and Equity

Todd Neale

August 04, 2023

Presentation TCT 2022

What Do the Guidelines Say?

Presenter: Ki Park

September 19, 2022

News Conference News TCT 2021

Crushed Prasugrel Loading Dose Still No Benefit at 1 Year in COMPARE CRUSH

Yael L. Maxwell

October 15, 2021

News Conference News SCCT 2021

As New Guidelines Loom, CT Community Seeks to Fill Knowledge Gaps

Yael L. Maxwell

July 20, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Daily News

CCTA to Avoid Invasive Cath in NSTE ACS? Clues From VERDICT

Shelley Wood

February 03, 2020

News Conference News ESC 2018

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

Shelley Wood

August 26, 2018

Presentation TCT 2017

TCT 16: Prospective, Multicenter Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold - Imaging Outcomes and Five-Year Clinical and Imaging Results

Presenter: Stephan Achenbach, Jacques J. Koolen, Stefan Verheye

October 31, 2017

Presentation TCT 2017

TCT 13: A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (FUTURE-I) - One-Year Clinical and Imaging Outcomes

Presenter: Stephan Achenbach, Jacques J. Koolen, Bo Xu

October 31, 2017

Presentation TCT 2017

TCT 14: Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With De Novo Lesions in Native Coronary Arteries at 12-Month Follow-up - BIOSOLVE-II and BIOSOLVE-III

Presenter: Stephan Achenbach, Jacques J. Koolen, Ron Waksman

October 31, 2017

Presentation TCT 2017

Case #8: Bioresorbable Scaffold Implantation in Left Main Coronary Artery - Feasibility and Wisdom (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Rajiv Ananthakrishna

October 30, 2017

Presentation TCT 2017

Case #7: Malapposition in a Bioresorbable Scaffold - Identification and the Decision Whether to Treat (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta

October 30, 2017

Presentation TCT 2017

Case #6: How to Implant Bioresorbable Scaffolds in Diffuse Disease (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta

October 30, 2017

Presentation TCT 2017

Case #5: How to Implant Bioresorbable Scaffolds in Calcified Lesions (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Antonio Colombo

October 30, 2017

Presentation TCT 2017

Case #4: How to Use Imaging During Bioresorbable Scaffold Implantation (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Daniel Chamie

October 30, 2017

Presentation TCT 2017

Case #3: How to Implant Bioresorbable Scaffolds in CTO (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Alessio G La Manna

October 30, 2017

Presentation TCT 2017

Case #2: How to Implant Bioresorbable Scaffolds in Bifurcation Lesions (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Javier Suárez de Lezo

October 30, 2017

Presentation TCT 2017

Case #1: How to Implant Bioresorbable Scaffolds in STEMI (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Petr Tousek

October 30, 2017

Advertisement

Leaders in Cardiac CT Look Back on 20 Years of Growth Despite Challenges

OCCUPI: OCT Guidance Improves Outcomes in Complex PCI

Do Guidelines Make a Difference? SCCT Session Probes Impact and Equity

What Do the Guidelines Say?

Crushed Prasugrel Loading Dose Still No Benefit at 1 Year in COMPARE CRUSH

As New Guidelines Loom, CT Community Seeks to Fill Knowledge Gaps

Roughly 80% of ESC Guideline Writers Have Financial COIs

CCTA to Avoid Invasive Cath in NSTE ACS? Clues From VERDICT

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

TCT 16: Prospective, Multicenter Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold - Imaging Outcomes and Five-Year Clinical and Imaging Results

TCT 13: A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (FUTURE-I) - One-Year Clinical and Imaging Outcomes

TCT 14: Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With De Novo Lesions in Native Coronary Arteries at 12-Month Follow-up - BIOSOLVE-II and BIOSOLVE-III

Case #8: Bioresorbable Scaffold Implantation in Left Main Coronary Artery - Feasibility and Wisdom (With Discussion)

Case #7: Malapposition in a Bioresorbable Scaffold - Identification and the Decision Whether to Treat (With Discussion)

Case #6: How to Implant Bioresorbable Scaffolds in Diffuse Disease (With Discussion)

Case #5: How to Implant Bioresorbable Scaffolds in Calcified Lesions (With Discussion)

Case #4: How to Use Imaging During Bioresorbable Scaffold Implantation (With Discussion)

Case #3: How to Implant Bioresorbable Scaffolds in CTO (With Discussion)

Case #2: How to Implant Bioresorbable Scaffolds in Bifurcation Lesions (With Discussion)

Case #1: How to Implant Bioresorbable Scaffolds in STEMI (With Discussion)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content